NHS Trusts: Medical Treatments
The question
To ask the Secretary of State for Health and Social Care, what steps he is taking to encourage NHS trusts to take part in clinical trials for innovative treatments.
Answered by Dr Zubir Ahmed
The Department is committed to turbocharging clinical research and encouraging National Health Service trusts to take part through the National Institute for Health and Care Research (NIHR) and a four-nation UK Clinical Research Delivery Programme (UKCRD).
The Department-funded NIHR funds research and research infrastructure, which supports patients, the public, and NHS settings to participate in high-quality research, including clinical trials for innovative treatments. NIHR infrastructure provides world-class research expertise, specialist facilities, a research delivery workforce, and support services. Through the NIHR’s Research Delivery Network (RDN), the NIHR supports all NHS trusts in England to deliver research, operating across 12 regions throughout the country.
In April 2025, the Department began publishing monthly key performance indicators on commercial clinical trial set up performance for NHS trusts in England, as part of the UKCRD programme, Study Set Up Plan. This report provides a monthly snapshot of site-level commercial study set-up performance, with the expectation that this will encourage NHS trusts to improve study set-up performance and therefore increase their participation in clinical trials for innovative treatments.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →